PTP4A3 and acute myeloid leukemia: Notably, in the present study, we demonstrate that PRL-3 may be a novel downstream target of FLT3-ITD signaling and expression of PRL-3 mRNA is significantly higher in AML patients with FLT3-ITD compared to wild type FLT-3.